AGI Ventures
Profile and fund size
AGI Ventures is the corporate venture arm of Alpha Genesis, a pharmaceutical and biotech company. It was founded in 2026 and is based in Yemassee, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences.
- Commitment by parentS2
- USD 50M
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Biotech and life sciences |
| Geography | North America |
| Offices | Yemassee, United States |
Sources: S1 AGI Ventures (Alpha Genesis): home; S2 Alpha Genesis press release: AGI Ventures launches with USD 50M commitment (2026-09-09).
Where it invests
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Alpha Genesis | Single source | S2 |
| Parent industry | Pharmaceuticals and biotech | Single source | S2 |
| Founded | 2026 | Single source | S2 |
| Headquarters | Yemassee, United States | Single source | S2 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S2 |
| Headline size | USD 50M (Commitment by parent) | Single source | S2 |
| Stages | Seed, Series A (inferred from announced rounds) | Estimate | S1 |
For founders
| Item | What the firm says | Source |
|---|---|---|
| Stages | Seed, Series A. Inferred from announced rounds; the firm does not state a range. | S1 |
| Pitch page | www.alphagenesisinc.com/ventures/apply | S1 |
Fund vehicles
| Vehicle | Size | Year | Source |
|---|---|---|---|
| AGI Ventures initial commitment | USD 50M | 2026 | S1 |
History
- Alpha Genesis launched AGI Ventures with an initial USD 50M commitmentS2
Official pages
Read the firm's own pages for current information.
- Website www.alphagenesisinc.com/ventures
- Pitch page www.alphagenesisinc.com/ventures/apply
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by AGI Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.